Biote corrects Q2 2022 net income down $9.4M; operating loss widened by $9.4M on omitted deal costs

biote Corp.

Corrected Q2 2022 net income $40.3M (was $49.7M); operating loss $(85.6M) (was $(76.2M)).
Six-month net income now $49.7M (was $59.1M); operating loss $(75.8M) (was $(66.4M)).
Omitted $7.2M in excess fair value of shares and $2.2M consulting costs related to May 2022 business combination.
Revenue of $47.5M and adjusted EBITDA of $13.1M for Q2 2022 were not impacted.
Full-year 2022 guidance for revenue and adjusted EBITDA remains unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.